• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型抗精神病药物能改善认知功能吗?

Do atypical antipsychotics improve cognition?

作者信息

Walters Yasmin, Agius Mark

机构信息

University of Cambridge, School of Clinical Medicine, St. Catharine's College, Cambridge, UK,

出版信息

Psychiatr Danub. 2014 Nov;26 Suppl 1:285-8.

PMID:25413554
Abstract

One of the major symptoms of schizophrenia is cognitive deficits. Despite this, these impairments still lack an effective treatment. It was hoped that atypical antipsychotics would treat these symptoms better than their first generation counterparts, but unfortunately the likes of quetiapine and clozapine did not do so. Asenapine and lurasidone, two newer atypicals, have shown promise, as have agents that interact with the glutamate system. Another approach has been to add agents such as modafinil. More research is needed to consolidate the findings of these studies.

摘要

精神分裂症的主要症状之一是认知缺陷。尽管如此,这些损伤仍缺乏有效的治疗方法。人们曾希望非典型抗精神病药物比第一代同类药物能更好地治疗这些症状,但不幸的是,喹硫平和氯氮平之类的药物并未达到预期效果。阿立哌唑和鲁拉西酮这两种较新的非典型药物已显示出前景,与谷氨酸系统相互作用的药物也是如此。另一种方法是添加如莫达非尼之类的药物。需要更多研究来巩固这些研究的结果。

相似文献

1
Do atypical antipsychotics improve cognition?非典型抗精神病药物能改善认知功能吗?
Psychiatr Danub. 2014 Nov;26 Suppl 1:285-8.
2
Atypical antipsychotics: mechanism of action.非典型抗精神病药物:作用机制
Can J Psychiatry. 2002 Feb;47(1):27-38.
3
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.一项针对使用奥氮平治疗的精神分裂症门诊患者结局的开放性、大型、为期6个月的自然主义研究。
Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9.
4
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.氯氮平、奥氮平、喹硫平和利培酮对精神分裂症神经心理影响的荟萃分析。
Int J Neuropsychopharmacol. 2005 Sep;8(3):457-72. doi: 10.1017/S146114570500516X. Epub 2005 Mar 23.
5
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.抗精神病药物联合治疗的利弊:2008年3月于法国尼斯召开的欧洲神经精神药理学会(ECNP)共识会议
Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.
6
Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.
Int Clin Psychopharmacol. 2003 May;18(3):121-32. doi: 10.1097/01.yic.0000063501.97247.38.
7
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.非典型抗精神病药物:精神分裂症治疗的新方向与新挑战
Annu Rev Med. 2001;52:503-17. doi: 10.1146/annurev.med.52.1.503.
8
[Atypical antipsychotic drugs].[非典型抗精神病药物]
Ned Tijdschr Geneeskd. 2000 Aug 19;144(34):1627-30.
9
Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.氯氮平对多巴胺D1和D2受体的等效占有率:与其他非典型抗精神病药物的区别
Am J Psychiatry. 2004 Sep;161(9):1620-5. doi: 10.1176/appi.ajp.161.9.1620.
10
Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.评估抗精神病药物对精神分裂症认知功能的影响。临床试验评估协作工作组。
J Clin Psychiatry. 1998;59 Suppl 12:35-40.

引用本文的文献

1
Clinical decision-making before discharge in hospitalized persons with schizophrenia: a Spanish Delphi expert consensus.精神分裂症住院患者出院前的临床决策:西班牙德尔菲专家共识
Front Psychiatry. 2024 Jun 10;15:1412637. doi: 10.3389/fpsyt.2024.1412637. eCollection 2024.
2
Reduced Hippocampal Volume and Its Relationship With Verbal Memory and Negative Symptoms in Treatment-Naive First-Episode Adolescent-Onset Schizophrenia.治疗初发的青少年起病精神分裂症患者海马体积缩小及其与言语记忆和阴性症状的关系。
Schizophr Bull. 2021 Jan 23;47(1):64-74. doi: 10.1093/schbul/sbaa092.
3
Effect of pre- and post-treatment with (Brahmi) on phencyclidine-induced disruptions in object recognition memory and cerebral calbindin, parvalbumin, and calretinin immunoreactivity in rats.
(婆罗米)预处理和后处理对苯环利定诱导的大鼠物体识别记忆障碍以及大脑钙结合蛋白、小白蛋白和钙视网膜蛋白免疫反应性的影响。
Neuropsychiatr Dis Treat. 2019 May 1;15:1103-1117. doi: 10.2147/NDT.S193222. eCollection 2019.
4
Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores.中枢神经系统多受体配体的研发:已知D2药效基团的修饰。
Bioorg Med Chem. 2016 Aug 15;24(16):3671-9. doi: 10.1016/j.bmc.2016.06.011. Epub 2016 Jun 4.
5
Time to Re-focus onto Cognitive Symptoms in Schizophrenia.是时候重新关注精神分裂症的认知症状了。
Indian J Psychol Med. 2016 Mar-Apr;38(2):93-6. doi: 10.4103/0253-7176.178765.
6
Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.催产素增强疗法治疗精神分裂症的疗效与安全性:随机安慰剂对照试验的最新系统评价与荟萃分析
Eur Arch Psychiatry Clin Neurosci. 2016 Aug;266(5):439-50. doi: 10.1007/s00406-015-0634-9. Epub 2015 Aug 25.